More and more research nails are being hammered into the coffin of breast screening and the subsequent treatments. The following article by Dr Dach is a must read for everyone.
There are links to other articles at the end of this post that will help readers with deciding what to do if they have concerns about breast cancer risk and prevention.
Gary
__________________________________________
There are links to other articles at the end of this post that will help readers with deciding what to do if they have concerns about breast cancer risk and prevention.
Gary
__________________________________________
Posted on:
Friday, August 2nd 2013 at 4:30 pmDr Laura Esserman of the University of California startled the medical community with an article questioning screening mammography published in the Journal of the American Medical Association (JAMA ). Dr Laura Esserman reviewed 20 years of breast cancer data. Her conclusion is not favorable:
"Mammography screening for breast cancer has significant drawbacks, and expected survival benefits have not materialized. "
"While the incidence of early stage breast cancer has decreased due to mammography, the incidence rates for the killer cancers, (the advanced cancers) have remained stable. While it is true that overall mortality rates have declined slightly, this is attributed to better treatment rather than increased detection."
Let's take a look at the Data Charts Dr Esserman used for her JAMA Article. ( Below Image Courtesy of Rethinking Screening for Breast Cancer and Prostate Cancer Laura Esserman, MD, JAMA. 2009;302(15):1685-1692.)Dr Laura Esserman.
The above chart shows the critical
information in Dr Esserman's JAMA article. The Pink line is
TOTAL breast cancer incidence annually. Note increase beginning in 1983
with introduction of mammography screening. Below the pink line, we
see three more lines: this is the breakdown of the total incidence into
localized, regional and metastatic cases. The turquoise line is
localized cancer. The light purple line is regional cancer and the black
line (lowest) is metastatic cancer. The killer cancers are the
regional and metastatic cases. Note that these numbers have remained
stable with little change in spite of detection of massive numbers of
localized cases
Further reading:
http://blog.garymoller.com/2012/04/why-women-should-avoid-mammograms.html
http://blog.garymoller.com/2012/12/30-years-of-breast-screening-13-million.html
http://blog.garymoller.com/2012/05/breast-thermograms-are-now-available-in.html
http://blog.garymoller.com/2013/05/the-evidence-mounts-mamograms-are-not.html
No comments:
Post a Comment